NIH #5R33CA278392-02
Micro-capsules for versatile multiplexed cytometry
- Amount
- $336K
- Period
- 2023-04-07 → 2026-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at HARVARD MEDICAL SCHOOL
Linas Mažutis
Full Professor(heuristic)
Single-cell and spatial transcriptomics · Molecular Biology
h-index43
i10-index62
Publications174
Citations19,363
Grants
3 total · 0 active
NIH #1R33CA278392-01
Micro-capsules for versatile multiplexed cytometry
- Amount
- $370K
- Period
- 2023-04-07 → 2026-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at HARVARD MEDICAL SCHOOL
NIH #3R33CA278392-02S1
IMAT-ITCR Collaboration: Multiplexed Spatial Data Calibration and analysis using micro-capsules
- Amount
- $85K
- Period
- 2024-09-01 → 2025-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at HARVARD MEDICAL SCHOOL
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Career Trajectory
Research Cluster Map
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Potential Collaborators
Recent Publications
Last 2 years · showing 20 of 55Hierarchical classification of immune cell transcriptomes at population-scale
bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-04
Table S1 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure S4 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure S6 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Table S8 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Table S10 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure 1 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure 5 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure 2 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Table S5 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Data from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure 4 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure S1 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure S8 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure S10 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Table S4 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Table S9 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure S3 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Table S3 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02
Figure S2 from Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer
2026-04-02